(Q42668393)

4 November 2017

title

Calpastatin subdomains A and C are activators of calpain (English)

1 reference

4 November 2017

Peter Tompa

1

1 reference

4 November 2017

Zoltan Mucsi

series ordinal

2

1 reference

4 November 2017

Gyorgy Orosz

series ordinal

3

1 reference

4 November 2017

Peter Friedrich

series ordinal

4

1 reference

4 November 2017

language of work or name

English

0 references

publication date

23 January 2002

1 reference

Journal of Biological Chemistry

4 November 2017

published in

1 reference

4 November 2017

volume

277

1 reference

4 November 2017

issue

11

1 reference

4 November 2017

page(s)

9022-9026

1 reference

Structure and physiological function of calpains

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100700200

The structure of calpain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100700200

Crystal structure of calpain reveals the structural basis for Ca(2+)-dependent protease activity and a novel mode of enzyme activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100700200

The crystal structure of calcium-free human m-calpain suggests an electrostatic switch mechanism for activation by calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100700200

Autolysis parallels activation of mu-calpain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100700200

Autolysis of human erythrocyte calpain produces two active enzyme forms with different cell localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100700200

Mechanism of action of a new component of the Ca(2+)-dependent proteolytic system in rat brain: the calpain activator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100700200

Requirement of different subdomains of calpastatin for calpain inhibition and for binding to calmodulin-like domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100700200

Preference of calcium-dependent interactions between calmodulin-like domains of calpain and calpastatin subdomains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100700200

Recombinant calpain II: improved expression systems and production of a C105A active-site mutant for crystallography

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100700200

Pig heart calpastatin: identification of repetitive domain structures and anomalous behavior in polyacrylamide gel electrophoresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100700200

Changes in intracellular localization of calpastatin during calpain activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100700200

Macromolecular crowding: obvious but underappreciated

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100700200

Disruption of the murine calpain small subunit gene, Capn4: calpain is essential for embryonic development but not for cell growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100700200

Evidence for participation of a calpain-like cysteine protease in cell cycle progression through late G1 phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100700200

Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100700200

Inhibition of calpain blocks platelet secretion, aggregation, and spreading

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100700200

Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of "pathological apoptosis"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100700200

Calpain inhibition: an overview of its therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100700200

A survey of calpain inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100700200

An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100700200

Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100700200

Functional defects of a muscle-specific calpain, p94, caused by mutations associated with limb-girdle muscular dystrophy type 2A

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100700200

Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100700200

A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100700200

Development and therapeutic potential of calpain inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100700200

Autolysis of Calcium-Activated Neutral Protease of Chicken Skeletal Muscle1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100700200

Domain III of calpain is a ca2+-regulated phospholipid-binding domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100700200

A novel aspect of calpain activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100700200

All four internally repetitive domains of pig calpastatin possess inhibitory activities against calpains I and II

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100700200

Reversible interaction between Ca2+-activated neutral protease (CANP) and its endogenous inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100700200

Caspases cleave the amino-terminal calpain inhibitory unit of calpastatin during apoptosis in human Jurkat T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100700200

Differential degradation of calpastatin by mu- and m-calpain in Ca(2+)-enriched human neuroblastoma LAN-5 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100700200

21 January 2018

Identifiers

DOI

10.1074/JBC.C100700200

1 reference

4 November 2017

1 reference